Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA
Nature Medicine2014Vol. 20(4), pp. 430–435
Citations Over TimeTop 1% of 2014 papers
Alain R. Thierry, Florent Moulière, Safia El Messaoudi, Caroline Mollévi, Evelyne Lopez‐Crapez, Fanny Rolet, Brigitte Gillet, Céline Gongora, Pierre Dechelotte, Bruno Robert, Maguy Del Rio, Pierre‐Jean Lamy, Frédéric Bibeau, Michelle Nouaille, Virginie Loriot, A.S. Jarrousse, Franck Molina, Muriel Mathonnet, Denis Pezet, Marc Ychou
Related Papers
- → Urinary Cell-Free DNA in Liquid Biopsy and Cancer Management(2022)41 cited
- → Comparison of digital PCR systems for the analysis of liquid biopsy samples of patients affected by lung and colorectal cancer(2023)33 cited
- → Monitoring KRAS mutations in circulating DNA and tumor cells using digital droplet PCR during treatment of KRAS -mutated lung adenocarcinoma(2016)61 cited
- → Detection and quantification of EGFR T790M mutation in liquid biopsies by droplet digital PCR(2021)29 cited
- → Droplet digital PCR, a new approach to analyze fetal DNA from maternal blood: application to the determination of fetal RHD genotype(2016)11 cited